Last Updated: August 2, 2026

Litigation Details for Acceleration Bay, LLC v. Amazon Web Services, Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Acceleration Bay, LLC v. Amazon Web Services, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Last updated: July 21, 2026

celeration Bay, LLC v. Amazon Web Services, Inc. (1:22-cv-00904): Litigation Summary, Claims at Issue, and Outcome Drivers

Executive summary
The docket entry set provided for Acceleration Bay, LLC v. Amazon Web Services, Inc. (1:22-cv-00904) is not sufficient to produce a complete, accurate litigation summary and analysis.

H1: Acceleration Bay, LLC v. Amazon Web Services, Inc. 1:22-cv-00904 litigation summary and patent claims

What is the case posture of Acceleration Bay v. AWS (1:22-cv-00904)?

No docket contents, filings, or dispositive events were provided, so a reliable posture call cannot be stated.

What patents or claims does Acceleration Bay assert against AWS in 1:22-cv-00904?

No asserted patent numbers, claim charts, infringement theories, or accused AWS services were provided, so claim-level coverage cannot be summarized.

Which AWS products or services are accused in the complaint for 1:22-cv-00904?

No complaint allegations or identification of accused instrumentalities (services, instances, storage, networking, ML platforms, or APIs) were provided.

What defenses has AWS raised in 1:22-cv-00904 (noninfringement, invalidity, venue, standing)?

No motions to dismiss, invalidity contentions, claim construction positions, or summary judgment briefing were provided.

What is the Markman claim construction status in Acceleration Bay v. AWS?

No scheduling order, claim construction order, or hearing outcomes were provided.

Have there been PTAB proceedings tied to the asserted patents in 1:22-cv-00904?

No inter partes review, post-grant review, or ex parte reexamination links were provided.

What is the latest litigation event date for 1:22-cv-00904, and what happened?

No docket timeline or event list was provided.

How do infringement and invalidity arguments typically map for software and cloud patent cases like this one?

A case-specific mapping cannot be produced without the asserted patents, claim language, and AWS defenses raised in this docket.

What settlement or consent outcomes exist in the docket for 1:22-cv-00904?

No settlement agreement terms, consent judgments, stipulations of dismissal, or fee awards were provided.

What does the record imply for damages exposure in Acceleration Bay v. AWS?

Damages exposure cannot be quantified without a verdict/settlement basis, royalty positions, or dismissal posture.

How does 1:22-cv-00904 compare with other AWS cloud patent litigations?

Comparison requires at least the asserted patents and procedural posture in this case, which were not provided.

Key takeaways for investors and licensors

No reliable takeaways can be stated without the operative complaint, claim construction, motion record, and final dispositions.

FAQs

  1. What is the court and judge assigned to Acceleration Bay v. AWS 1:22-cv-00904?
  2. Which patents are listed as asserted in the infringement complaint?
  3. Was there a claim construction order in 1:22-cv-00904?
  4. Did AWS file a Paragraph IV or Hatch-Waxman-type challenge in this case?
  5. What is the final disposition of 1:22-cv-00904 (dismissal, settlement, verdict, or ongoing)?

References (APA)

  1. (No sources cited; no docket, complaint, order, or dispositive filings were provided.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.